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Background: We have preliminarily reported MTA2 expression in gastric cancer and its biological functions by
using knockdown cell models, while the molecular mechanisms of MTA2 in regulating malignant behaviors are still
unclear.
Methods: MTA2 overexpression models were established by transfection assay in gastric cancer cells BGC-823 and
MKN28. Cell proliferation assay, colony formation in soft agar, wound-healing assay and transwell migration assay were
performed with MTA2 overexpression and negative control (NC) cells. Subcutaneous xenografts and pulmonary metastasis
models by BGC-823/MTA2 and BGC-823/NC cells were used to observe the capacity of growth and metastasis in vivo.
Differential gene expression in MTA2 knockdown and overexpression cells was analyzed by microarrays. IL-11, which
demonstrated as differential expression in microarray, was detected by real-time PCR, western blot, ELISA and
immunohistochemistry staining. Recombinant human IL-11 (rhIL-11) was administrated in cell proliferation and
colony formation as rescue assay.
Results: The numbers of colonies in soft agar were significantly more in BGC-823/MTA2 and MKN28/MTA2 cells,
comparing with those in their NC cells. Capabilities of cell proliferation, wound-healing and cell migration were
not significantly changed in MTA2 overexpression cells. The sizes of subcutaneous xenografts and pulmonary
metastases of BGC-832/MTA2 cells were significantly larger than those in BGC-823/NC group. Differential
expression of IL-11 was identified by genome expression microarray both in MTA2 knockdown and overexpression
cells. IL-11 expression was elevated in BGC-823/MTA2 cells, whereas reduced in SGC-7901/shMTA2 cells.
Administration of rhIL-11 recovered colony formation capacity of SGC-7901/shMTA2 cells.
Conclusions: MTA2 overexpression enhances colony formation and tumor growth of gastric cancer cells, but not
plays important role in cancer cell migration and metastasis. IL-11 is one of the downstream effectors of MTA2 in
regulating gastric cancer cells growth.
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Gastric cancer is one of the most malignant gastrointes-
tinal neoplasms in the world [1]. In the past decades, al-
though its incidence is decreasing worldwide, gastric
cancer is still one of the leading causes of cancer-specific
mortality in mainland of China [2]. To improve the out-
come of gastric cancer patients, mechanisms of tumori-
genesis and progression are under investigation, and
intent to clinical translation. However, due to the multiple* Correspondence: jun_zj10977@163.com
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unless otherwise stated.molecular aberrances and high heterogeneity, relevant
molecular events of gastric cancer cells are far from eluci-
dated [3].
Metastasis associated 1 family, member 2 (MTA2) gene is
classified to metastasis associated gene family [4]. Like
MTA1, aberrant expression of MTA2 has been reported in
several tumors, including ovarian, lung and pancreatic can-
cer [5-7]. We have previously reported that MTA2 gene
was overexpressed in gastric cancer tissues, correlating with
tumor invasion, lymph node metastasis, and advanced
TNM stage. MTA2 knockdown significantly inhibited gas-
tric cancer cell invasion and metastasis [8]. Yet, its molecu-
lar mechanisms are still unclear.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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histone deacetylation (NuRD) complex, MTA2 is neces-
sary for assembly of a catalytically active histone deace-
tylase (HDAC) complex. HDAC activity is significantly
impaired without MTA2 [9]. Nucleosome remodeling
and histone deacetylation are the major processes for
gene transcriptional regulation [10]. Furthermore, MTA2
has been reported to form transcription complexes with
some transcription factors, such as ERα and Twist [11].
Those results indicate that impacts of MTA2 on bio-
logical function might via regulating specific genes
which were related with tumor malignant behaviors.
In present study, to validated MTA2 biological func-
tion, MTA2 overexpression cell models established by
MTA2 low expression gastric cancer cells were investi-
gated. Differential gene expression in MTA2 overexpres-
sion and knockdown cells was analyzed to identify its
downstream effectors. Meanwhile, the biological func-
tions of MTA2-downstream effectors were reversely
confirmed through rescue assay.
Methods
Cell lines and reagents
Gastric cancer cell lines BGC-823 and MKN28 were pre-
served in Shanghai Institution of Digestive Surgery.
MTA2 knockdown cell SGC-7901/shMTA2 and its
negative control cell SGC-7901/NC were described in
previous study [8]. All cells were cultured at 37°C with
5% CO2 in RPMI-1640 medium with 10% fetal calf
serum. Selection antibiotics, puromycin or hygromycin,
were added into medium if necessary.
Puromycin (Sigma) and hygromycin (Sigma) were re-
spectively dissolved by phosphate buffered saline (PBS)
at concentrations of 1 mg/ml and 200 mg/ml. Recom-
binant human interleukin-11 (rhIL-11, R&D systems)
was reconstituted following user manual at a concentra-
tion of 50 μg/ml. SAHA (Selleckchem) was dissolved by
DMSO at a concentration of 200 mM. All reagents were
divided into aliquots, and were stored at -80°C.
Establishment of MTA2 overexpression cell models
Full-length cDNA sequence of MTA2 gene (Gene ID:
9219) was cloned and constructed into vector with Flag-
tag. MTA2 plasmid and its negative control were pack-
aged into lentivirus, and were used to infect BGC-823
and MKN28 cells, respectively. Stable transfected cells
were selected by medium with hygromycin (200 μg/ml).
MTA2 overexpression cell models were named as BGC-
823/MTA2 and MKN28/MTA2, and negative controls
were named as BGC-823/NC and MKN28/NC.
RNA extraction and real-time PCR
Total cell RNA was extracted by Trizol reagent, and
their concentrations were determined by microplatespectrophotometer (BioTek). Reverse transcription was
performed following protocol of Applied Biosystems.
Real-time PCR was performed by ABI Prism 7900HT se-
quence detection system (Applied Biosystems). Primers
for real-time PCR were MTA2: F-TGT ACC GGG TGG
GAG ATT AC, R-TGA GGC TAC TAG AAA TGT
CCC TG; IL-11: F- ACA GCT GAG GGA CAA ATT
CC, R- AGC ACA CCT GGG AGC TGT AG. GAPDH
was used as reference gene.
Western blot
Whole cell proteins were extracted by RIPA reagent (Solar-
bio), and protein concentrations were determined by DC
protein assay (Bio-Rad). Denatured samples were fraction-
ated by SDS-PAGE gel and transferred to PVDF mem-
branes. Membranes were blocked by skim milk for 1 h at
room temperature. Primary antibodies, MTA2 (1:1000,
BETHYL), IL-11 (1:200, Santa cruz), β-actin (1:5000, Sigma)
and GAPDH (1:5000, KANGCHEN), were incubated over-
night at 4°C. Fluorescent secondary antibodies (1:15000, LI-
COR) were incubated at room temperature for 1 h. Protein
bands were visualized by infrared imaging system (LI-COR).
Immunofluorescence
Attached cells were fixed by 4% paraformaldehyde for
30 min, and penetrated by Triton X-100 for 15 min, then
blocked by BSA for 30 min. DYKDDDK Tag (9A3) mouse
mAb (1: 100, Cell signaling) was incubated at room
temperature for 1 h. After rinsed by PBS, Anti-mouse IgG1
FITC (1:100, eBioscience) was incubated for 30 min. Slides
were mounted by VECTASHIELD Mounting Medium with
DAPI (Vector Labs). Images were captured by confocal
microscope, with Zeiss LSM Image Examiner (Carl Zeiss).
Cell proliferation assay
One thousand cells per well were plated into 96-well
plates, and were cultured overnight. CCK-8 (Dojindo)
were added and incubated at 37°C for 2 h. Optical dens-
ity value was detected by microplate spectrophotometer
(BioTek). Cell growth curves were drawn.
Soft agar colony formation assay
Two milliliter medium with 0.4% agar was used as bottom
gel. One thousand cells were suspended in 4 ml medium
with 0.2% agar, and were poured on bottom gel. After
2 weeks, colonies were stained by MTT. Number of colonies
was counted at low power lens of microscopy. Size of col-
onies was analyzed by Colony Counter software (Tanon).
RhIL-11 was added at a concentration of 100 ng/ml.
Wound healing assay and migration assay
Cells were cultured as monolayer in 12-well plates. On
reaching more than 95% confluent, wounds were
scratched by pipette tips. After washed by PBS, wounds
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serum-free medium during the process.
Fifty thousand cells suspended in 100 μl serum-free
medium were added into upper chambers of Transwell
(8 μm for 24-well plate, Millipore), and full medium
were added into lower chambers. After 24 h, cells were
fixed by formalin, and stained by 0.1% crystal violet.
Nude mouse xenografts
BGC-823/MTA2 and BGC-823/NC cells were studied
in vivo. All mouse experiments were approved by the
Animal Care and Use Committee and conducted an ac-
cord with the Guide for the Care and Use Laboratory
Animals of Ruijin Hospital, Shanghai Jiaotong University
School of Medicine. Eight 4-week-old male Balb/c nude
mice (Institute of Zoology, Chinese Academy of Sci-
ences) were randomly divided into two groups before es-
tablishment of subcutaneous xenografts. One million
cells in 100 μl PBS were injected into subcutaneous tis-
sues of right side back. After tumor length exceeded
4 mm, tumors were measured every 7 days for 4 weeks,
and tumor volume was calculated by following formula:
V = (Width2 × Length)/2. At 5th week, tumor nodules
were collected, and fixed by 10% formalin.
In experimental metastasis assay, twenty Balb/c nude
mice (Institute of Zoology, Chinese Academy of Sciences)
were randomly divided into two groups. One million BGC-
823/MTA2 or BGC-823/NC cells in 100 μl PBS were
injected through tail vein, respectively. One mouse of each
group was sacrificed after one month to assess metastasis
formation. After two months, all mice were dissected. Pul-
mones were fixed by 10% formalin. Metastatic lesions were
counted in gross specimens, and were confirmed by HE
staining.
Immunohistochemistry staining (IHC)
Fixed tumor nodules were embedded by paraffin, and
were made into 4 μm-thick slices. IHC were performed
following EnVision two-step procedure of Dako™ REAL™
Envision Detection System (Dako). Primary antibodies
included MTA2 (1:200, Santa Cruz), Ki-67 (1:50, Dako),
IL-11 (1:100, Santa Cruz). Slices were visualized by
diaminobenzidine.
Microarray data
Differential gene expression between BGC-823/NC and
BGC-823/MTA2, SGC-7901/NC and SGC-7901/shMTA2
cells was analyzed, respectively. Total RNA of cells were
extracted by Trizol reagent. Whole human genome micro-
array 4 × 44 K (Design ID: 014850, Agilent technologies)
was used to detect gene expression profile following man-
ufacturer’s instructions. Raw data were normalized by
Quantile algorithm using Gene Spring Software 11.0 (Agi-
lent technologies). Genes with fold change >2 or <0.05and p-value <0.05 were identified. Microarray data are
available in the ArrayExpress database (www.ebi.ac.uk/
arrayexpress) under accession number E-MTAB-3469.
Enzyme-linked immunosorbent assay (ELISA)
Supernatants of SGC-7901/NC and SGC-7901/shMTA2
cells, BGC-823/NC and BGC-823/MTA2 cells were col-
lected, and were centrifuged to remove cell debris. Total
levels of IL-11 protein were measured by using human
IL-11 antibody (R&D system, MAB618). IL-11 levels
were normalized to amount of mRNA in each sample.
Statistics
Independent-samples t test, Mann-Whitney U test and
one-way ANOVA test (LSD post-hoc) were used to
analyze quantitive data. P-value <0.05 was considered as
statistical significant (*: P < 0.05; **: P < 0.01). The error
bars in all figures represented standard deviation. All
tests were preformed by SPSS 13.0 software (SPSS Inc.).
Results
MTA2 overexpression promoted cell colony formation in
soft agar
Introduction of MTA2 into BGC-823 and MKN28 cells
was confirmed by both real-time PCR and western blot
(Figure 1A). Immunofluorescence staining demonstrated
that exogenous MTA2 protein was localized in cell nu-
cleus (Figure 1B).
Growth curves of BGC-823/MTA2 and MKN28/MTA2
cells were similar, as compared with those in NC cells
(Figure 2A). In soft agar colony formation assay, more col-
onies were observed in MTA2 overexpression cells
(MTA2 vs. NC, BGC823: 15.8 ± 2.4 vs. 9.0 ± 1.2, P = 0.002;
MKN28: 21.0 ± 1.8 vs. 14.3 ± 1.0, P = 0.001, Figure 2B).
No differences were found between BGC-823/MTA2
and BGC-823/NC cells in wound-healing courses, as
well as those in MKN28/MTA2 and its NC cells (Fig-
ure 2C). In migration assay, the numbers of cells passed
through membrane were also similar between MTA2
overexpression and NC cells (MTA2 vs. NC, BGC-823:
17.0 ± 2.6 vs. 15.7 ± 2.5, P > 0.05; MKN28: 3.0 ± 1.0 vs.
4.0 ± 1.0, P > 0.05, Figure 2D).
MTA2 overexpression enhanced xenografts and
pulmonary metastases growth
Growth rate of subcutaneous xenografts in BGC-823/
MTA2 group was significantly faster than that in BGC-
823/NC group. At fourth week, tumor volume and
weight were significantly larger in BGC-823/MTA2
group than those in NC group (volume: 2885.7 ±
1109.8 mm3 vs. 1509.6 ± 133.2 mm3, P = 0.021; weight:
1.51 ± 0.58 g vs. 0.86 ± 0.17, P = 0.038, Figure 3A). Ki-67
staining was stronger in BGC-823/MTA2 xenografts
than that in NC (Figure 3B).
Figure 1 Establishment of MTA2 overexpression gastric cancer cell models. A: MTA2 expression in BGC-823 and MKN28 cells was detected by real-time
PCR and western blot. B: Exogenous MTA2 protein was localized in nucleus (immunofluorescence). “Immunofluorescence staining demonstrated that
exogenous MTA2 protein was localized in cell nucleus (Figure 1B).” “High magnification image was provided in Additional file 1: Figure S1.”
Figure 2 MTA2 overexpression enhanced cell colony formation in soft agar. A: Growth curves were similar between MTA2 overexpression and
NC cells. B: The number of colonies formed in soft agar was more in MTA2 overexpression cells than it in NC cells. C: Wound-healing courses
were similar between MTA2 overexpression and NC cells. D: The numbers of cells passed though membrane were not different between MTA2
overexpression and NC cells.
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Figure 3 MTA2 overexpression in BGC-823 cell enhanced growth of subcutaneous xenografts and pulmonary metastases. A: Size and weight of
subcutaneous xenografts in BGC-823/MTA2 group were larger than those in BGC-823/NC group. B: Ki-67 staining in BGC-823/MTA2 group was
stronger than it in BGC-823/NC group. C: Size of pulmonary metastases in BGC-823/MTA2 group was larger than those in BGC-823/NC group,
while numbers of lesions were not significantly different.
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BGC-823/MTA2 group, the volume of metastatic lesions
was larger than those in BGC-823/NC group (Figure 3C).
However, the number of metastases was no difference
between those two groups (MTA2 vs. NC: 43.8 ± 56.7 vs.
26.2 ± 26.7, P > 0.05, Figure 3C).
IL-11 was identified as a differential expressed gene by
microarray
Differential gene expression between BGC-823/MTA2
and BGC-823/NC cells as well as SGC-7901/shMTA2and SGC-7901/NC cells were analyzed. Overlapped dif-
ferential genes between those two data sets were identi-
fied. IL-11 demonstrated the most significant fold
changes in both data sets (Table 1).
IL-11 mRNA was significantly changed in SGC-7901/
shMTA2 and BGC-823/MTA2 cells, as the results of
microarray (P < 0.01, Figure 4A). IL-11 protein was also
reduced in SGC-7901/shMTA2 cells, and slightly elevated
in BGC-823/MTA2 cells by western blot, as well as in
ELISA test (SGC-7901/NC vs. SGC-7901/shMTA2:
1.89 ± 0.33 vs. 0.81 ± 0.35, P < 0.01; BGC-823/NC vs.
Table 1 Differential gene expression in MTA2 overexpression and knockdown cells
Gene MTA2 overexpression MTA2 knockdown Description
Fc P value Fc P value
IL-11 7.3145 7.74E-06 0.2631 0.0054 Interleukin 11
TXNIP 2.8848 0.0006 0.0176 1.54E-05 Thioredoxin interacting protein
AIM1L 0.4801 0.0071 2.1508 0.0013 Absent in melanoma 1-like
KLK1 0.4736 0.0039 2.7208 0.0009 Kallikrein 1
RAET1E 0.4116 0.0027 6.1737 0.0017 Retinoic acid early transcript 1E
KCNQ2 0.3869 0.0009 2.6920 0.0001 Potassium voltage-gated channel, KQT-like subfamily, member 2
NES 0.3735 0.0015 2.9488 0.0001 Nestin
HSPA2 0.3183 0.0009 2.1676 0.0068 Heat shock 70 kDa protein 2
SUSD2 0.3074 0.0017 2.5593 3.79E-06 Sushi domain containing 2
MFAP5 0.3055 0.0049 3.1193 0.0043 Microfibrillar associated protein 5
OLAH 0.2559 8.55E-05 2.3232 0.0032 Oleoyl-ACP hydrolase
ALPPL2 0.2195 0.0004 2.0811 0.0004 Alkaline phosphatase, placental-like 2
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Figure 4B). IHC showed that IL-11 expression was reduced
in SGC-7901/shMTA2 xenografts, and was significantly in-
creased in BGC-823/MTA2 xenografts (Figure 4C).IL-11 expression was reduced by HDAC inhibitor SAHA
After SAHA treatment (4 μM for 24 h), IL-11 mRNA in
SGC-7901/NC cells was significantly decreased (P <
0.01), and similar with the level in SGC-7901/shMTA2
cells treated by DMSO. In BGC-823/NC cells, IL-11
mRNA was not changed by SAHA (P > 0.05), while its
expression in BGC-823/MTA2/SAHA group was signifi-
cantly decreased (P < 0.01, Figure 4D).IL-11 recovered colony formation capacity of MTA2
knockdown cells
SGC-7901/shMTA2 and SGC-7901/NC cells were
treated by rhIL-11 (100 ng/ml). In cell proliferation
assay, cell growth rates were not significantly changed
among cells treated by rhIL-11 or PBS (Figure 5A).
In colony formation assay, the colony number of SGC-
7901/shMTA2 cells treated by rhIL-11 was more than
those treated by PBS (SGC-7901/shMTA2: rhIL-11 vs.
PBS, 25.6 ± 1.5 vs. 20.0 ± 2.3, P < 0.01), and was similar
with the number of SGC-7901/NC/PBS group (24.4 ±
4.1, P = 0.566). The number of colonies of SGC-7901/
NC cells treated by rhIL-11 was also more than those
treated by PBS (SGC-7901/NC: rhIL-11 vs. PBS, 30.4 ±
4.2 vs. 24.4 ± 4.1, P < 0.01, Figure 5C). The average size
of colonies was also larger in SGC-7901/shMTA2/rhIL-
11 group than that in SGC-7901/shMTA2/PBS group
(14.6 ± 5.0 vs. 12.6 ± 3.3, P = 0.004, Figure 5D).Discussion
Herein, we found that MTA2 overexpression in gastric can-
cer increased colony formation in vitro and tumor growth
in vivo, including either subcutaneous xenografts or pul-
monary metastases. By genome expression analysis, IL-11
expression was found to be in accordance with down- and
up-regulation of MTA2. Recombinant human IL-11 treat-
ment could recover colony formation capacity of MTA2
knockdown cells.
The biological functions of MTA2 in cancer have not
been fully investigated. MTA2 was first identified in
quickly dividing cells in cervical cancer [9]. In non-
small cell lung cancer, ki-67 index in MTA2 positive tis-
sues was higher than that in negative ones [6]. MTA2
overexpression could increase colony formation of
osteosarcoma cells SaoS-2 by inhibiting p53 activity,
and also enhanced ER-α positive breast cancer cells
growth [12,13]. On the other hand, in mouse breast can-
cer 4 T1 cells and glioma cells, it was reported that
MTA2 knockdown impaired cell invasion and metasta-
sis [11,14]. Those results showed that MTA2 played role
in various malignant behaviors, including proliferation,
invasion and metastasis. However, few studies assessed
the biological function of MTA2 in both overexpression
and knockdown manners.
We have previously reported that MTA2 knockdown
in SGC-7901 and AGS gastric cancer cell lines with high
MTA2 expression inhibited gastric cancer cell invasion
and metastasis. Although attenuated cell colony forma-
tion and subcutaneous tumor growth were observed,
these phenomena were attributed to the impaired cell
invasion. Changes of cells morphology and reduced
CD24 and MYLK expression further supported the con-
clusion that depression of cell mobility could be the
Figure 4 IL-11 expression related with MTA2 in SGC-7901 and BGC-823 cells. A: IL-11 expression was detected by real-time PCR. B: IL-11 protein
was detected by western blot and ELISA. C: IL-11 expression in SGC-7901 and BGC-823 xenografts was detected by IHC. D: IL-11 mRNA expression
was reduced by SAHA in both SGC-7901/NC cell and BGC-823/MTA2 cell.
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cer cells [8].
To verify those phenomena, cell models based on gas-
tric cancer cells with different genetic background were
preferred to be used. Therefore, BGC-823 and MKN28
cell lines with low MTA2 expression was used to estab-
lish MTA2 knock-in cell models. From the results, we
found that enhanced cell migration was not observed in
MTA2 overexpression cells. Although CD24 and MYLK
were identified by genome expression analysis in MTA2
knockdown cells as pervious reported, those two genes
was not found in our MTA2 overexpression date set. In-
stead of cell invasion, colony formation in soft agar and
tumor growth in vivo were significantly enhanced byMTA2 overexpression, contrast to MTA2 knockdown.
Positive correlation between Ki-67 and MTA2 was de-
tected in both MTA2 knockdown and overexpression
xenografts. Those results demonstrated that in gastric can-
cer cells, MTA2 was strongly related with cell colony forma-
tion and tumor growth. MTA2 participated in gastric cancer
cell invasion, but might not be a dominant regulator.
The different results between cell proliferation assay
and in vivo experiments indicated that interactions be-
tween tumor cells and its microenvironment could cor-
relate with growth promoting effect of MTA2 [15].
Intercellular contact, growth factors, cytokines and
extracellular matrix, all play important roles in tumor
growth of gastric cancer [16]. In present study, IL-11
Figure 5 IL-11 recovered colony formation capacity of SGC-7901/shMTA2 cell. A: Growth curves of SGC-7901/NC and SGC-7901/shMTA2 cells were not
affected by rhIL-11 treatment. B: Colony formation in soft agar was assessed after rhIL-11 treatment. C: Number of colonies in SGC-7901/shMTA2/IL-11 group
was more than it in SGC-7901/shMTA2/PBS group, and similar with SGC-7901/NC/PBS group. D: Size of colonies in SGC-7901/shMTA2/IL-11 group was larger
than it in SGC-7901/shMTA2/PBS group.
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cer cells by genome expression analysis, and was vali-
dated in both cell models and xenografts tissues.
IL-11 belongs to IL-6 cytokine family, which consisted of
IL-6, IL-11, IL-27, IL-30, IL-31, oncostatin M, and others,
and it can be secreted by cancer-associated fibroblasts, mye-
loid cells, and tumor cell itself [17,18]. Aberrant expression
of IL-11 and its receptor IL-11Rα was found in gastric can-
cer tissues, and correlated with Lauren’s classification, tumor
invasion and vessel infiltration [19]. In transgenic mice
model carrying gp130Y757F/Y757F, the IL-11 receptor with
substitution of tyrosine (Y) 757 by phenylalanine (F), spon-
taneous gastric tumorigenesis is found. This mutation abol-
ished negative feedback of gp130, resulting consistent
activation of IL-11 downstream signaling pathway [20].Gastric tumor formed in gp130Y757F/Y757F mice could be sig-
nificantly abrogated by IL-11Rα knock-out and also by IL-
11 signaling antagonist. Those results demonstrated that IL-
11 was one of the dominant factors in gastric cancer devel-
opment and progression [21,22].
To validate whether IL-11 was involved in cell colony for-
mation regulated by MTA2, rhIL-11 was used to treat
MTA2 knockdown cells in present study. Administration of
rhIL-11 recovered colony formation ability of MTA2 knock-
down cells and could further enhance it in NC cells, while
cell proliferation was not effected by rhIL-11. Colony forma-
tion of BGC-823 cell could also enhanced by IL-11 treat-
ment (Additional file 2: Figure S2). On the other hand, by
using antibody to neutralize IL-11 function in BGC-823/
MTA2 cell, its colony formation was impaired (Additional
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promoting gastric cancer cell colony formation might par-
tially through IL-11 as a downstream effector.
The mechanisms of MTA2 in regulating gene expression
are currently obscure. Because of its role in NuRD complex
to maintain HDAC activity, the impact of MTA2 on IL-11
expression could partially via HDAC pathway. Therefore, we
used HDAC inhibitor to simulate the status of MTA2
knockdown. After SAHA treatment, IL-11 expression was
significantly reduced in SGC-7901/NC cell, and its level was
similar to MTA2 knockdown cells. IL-11 expression in
MTA2 overexpression cells was also decreased. Those re-
sults indicated that HDAC activity regulated by MTA2
might involve in regulating IL-11 expression.
Not only participates in NuRD complex formation,
MTA2 could also form complexes with some transcription
factors, resulting in gene transcriptional repression. Inter-
action of MTA2 and Twist participated in repressing E-
cadherin promoter activity [11]. Binding with ERα, MTA2
could repress its transcriptional activity in breast cancer
cells [13]. In present study, increased expression of IL-11 in
MTA2 overexpression cells indicated that MTA2 could
promote specific gene expression, and its mechanism
should be investigated in further studies.
Besides IL-11, several genes were identified by genome ex-
pression analysis. Some of those genes had been investigated
in cancer cells, while the functions of others were still un-
clear. TXNIP is an endogenous antagonist of TRX, and can
regulate cellular redox equilibrium by repressing TRX activ-
ity [23]. Expression of RAETI1E was correlated with poor
prognosis of ovarian cancer patients [24]. Biological func-
tions of HSPA2 had also been investigated in several tumors
[25,26]. The roles of those genes in malignant behaviors reg-
ulated by MTA2 should be further explored.
Conclusions
MTA2 overexpression enhances colony formation and
tumor growth of gastric cancer cells, but does not promote
tumor migration and metastasis. IL-11 is one of the down-
stream effectors of MTA2 in regulating gastric cancer cells
growth.
Additional files
Additional file 1: Figure S1. Immunofluorescence staining of MTA2 in
MTA2 overexpression cells. Immunofluorescence staining showed that
exogenous MTA2 localized in cellular nucleus.
Additional file 2: Figure S2. Colony formation of BGC-823 cells was
enhanced by IL-11. BGC-823 cells in soft agar were treated by IL-11 and
PBS, respectively. The method was described in manuscript. Results
showed that number and size of colonies in BGC-823/IL-11 group was
more than those in BGC-823/PBS group (IL-11 vs. PBS, number: 12.8 ± 2.4
vs. 9.2 ± 1.3, P = 0.018; size 70.0 ± 47.8 vs. 50.0 ± 34.8, P < 0.001).
Additional file 3: Figure S3. Colony formation of BGC-823/MTA2 cells
was reduced by IL-11 antibody. BGC-823/MTA2 cells in soft agar weretreated by IL-11 antibody (R&D systems, #22626, 10 μg/ml) and PBS,
respectively. Results showed that number of colonies in BGC-823/MTA2/
anti-IL11 group was less than those in BGC-823/MTA2/PBS group (5.8 ±
0.8 vs. 13.6 ± 3.4, P = 0.001). Size of colonies between those two groups
was similar (30.4 ± 19.4 vs. 36.2 ± 28.9, P = 0.194).
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